Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 12, 2020

Total Value ($000): $236,102 (100.0% shares, 0.0% debt)

Holdings (17)

INSM INSMED INC 14.4%
Value ($000) $33,965 Shares 1,056,797 Est. Cost $20.81 Unrealized +38.1%
ACAD ACADIA PHARMACEUTICALS INC 11.3%
Value ($000) $26,723 Shares 647,833 Est. Cost $43.17 Unrealized +0.0%
TRILLIUM THERAPEUTICS INC 9.4%
Value ($000) $22,142 Shares 1,558,181 Est. Cost $4.53 Unrealized
FOLD AMICUS THERAPEUTICS INC 8.7%
Value ($000) $20,550 Shares 1,455,395 Est. Cost $9.80 Unrealized +48.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 8.3%
Value ($000) $19,650 Shares 596,890 Est. Cost $24.87 Unrealized +23.3%
ZOGENIX INC 8.0%
Value ($000) $18,950 Shares 1,056,875 Est. Cost $36.29 Unrealized
AXSM AXSOME THERAPEUTICS INC 6.6%
Value ($000) $15,682 Shares 220,098 Est. Cost $80.87 Unrealized -3.6%
UNUM THERAPEUTICS INC 5.8%
Value ($000) $13,716 Shares 6,235,903 Est. Cost $2.20 Unrealized
ALLAKOS INC 5.7%
Value ($000) $13,412 Shares 164,662 Est. Cost $81.12 Unrealized
ARGX ARGENX SE 5.6%
Value ($000) $13,113 Shares 49,950 Est. Cost $160.52 Unrealized
KARYOPHARM THERAPEUTICS INC 4.3%
Value ($000) $10,254 Shares 702,351 Est. Cost $18.82 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 3.1%
Value ($000) $7,427 Shares 162,236 Est. Cost $61.59 Unrealized -21.3%
AMARIN CORP PLC 2.7%
Value ($000) $6,350 Shares 1,508,237 Est. Cost $14.78 Unrealized
MIRATI THERAPEUTICS INC 2.5%
Value ($000) $5,812 Shares 35,000 Est. Cost $166.06 Unrealized
NEOLEUKIN THERAPEUTICS INC 1.9%
Value ($000) $4,473 Shares 372,748 Est. Cost $12.32 Unrealized
KINIKSA PHARMACEUTICALS LTD 1.4%
Value ($000) $3,259 Shares 212,746 Est. Cost $12.03 Unrealized
VERONA PHARMA PLC 0.3%
Value ($000) $624 Shares 100,000 Est. Cost $6.24 Unrealized